COVID-19 vaccine uptake and associated factors among individuals living in a peri-urban area in Uganda: a cross-sectional study
dc.contributor.author | Nanteza, Bridget Mary | |
dc.contributor.author | Nanyonjo, Gertrude | |
dc.contributor.author | Kyakuwa, Nasimu | |
dc.contributor.author | Nakanjako, Flavia | |
dc.contributor.author | Kalute, Hamza | |
dc.contributor.author | Atuhairwe, Christine | |
dc.contributor.author | Watera, Christine | |
dc.contributor.author | Ssemwanga, Deogratius | |
dc.date.accessioned | 2025-06-26T13:50:11Z | |
dc.date.available | 2025-06-26T13:50:11Z | |
dc.date.issued | 2024-11-04 | |
dc.description.abstract | Introduction: The Corona virus disease (COVID-19) is a respiratory illness that is caused by SARS-CoV-2 virus. This virus was first reported in China in December 2019. It then spread to all countries and from March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. In Uganda, the disease was first reported in March 2020 and COVID-19 vaccines became available by January 2021. Although COVID-19 vaccines were available in Uganda, uptake remained low. The aim of this study was to establish COVID-19 vaccine uptake awareness in a peri-urban setting in Entebbe City, Uganda. Methods: This was a cross-sectional study conducted among 127 men and 263 women who reside in Entebbe City, Uganda. Data was collected on socio-behavioral characteristics, knowledge, attitude, and practice (KAP) about COVID-19 vaccine using interviewer administered questionnaires. Uptake of COVID-19 vaccine was defined as the proportion of participants who had received at least one dose of the COVID-19 vaccine. We used descriptive statistics to estimate awareness of COVID-19 vaccines. The 'chi-square test' and 'modified Poisson regression' were used to assess variations in uptake of COVID-19 vaccines among respondents and their socio-demographics as well as other characteristics. Results: Ninety-nine percent (388 out of 390) of the study population were aware of at least one brand of COVID-19 vaccines in the country. Thirty-five percent (138 out of 390) knew that the vaccine immunity was achieved 14 days after the 2nd dose and 98.7% (385 out of 390) admitted that observing the standard operating procedure for COVID-19 infection prevention was necessary after vaccination. There was a gap in knowledge on vaccine safety reported by 74.6% (291 out of 390) participants. Some participants 37.2% (145 out of 390) had concerns about the vaccine. Of these, 57.9% (84 out of 145) believed that the vaccines were not helpful; and 30.3% (44 out of 145) feared serious side effects. Sixty-six percent (257 out of 390) believed that vaccines were not working and 79.0% (308 out of 390) admitted that vaccines were promoted for financial gain. At the time of performing the study, 36.2% and 22.3% had received the 1st and 2nd dose respectively. The main sources of information on COVID-19 vaccine were television (TV) and social media (p-value 0.001). In a multivariate model, COVID-19 vaccine acceptability was associated with salaried and self-employment (p-value 0.046). The other predicative factors were awareness of the COVID-19 vaccine (p-value <0.001) and having vaccine concerns (p-value 0.013). Conclusion: Uptake of COVID-19 vaccination in Entebbe community was low, partly attributed to knowledge gaps and concerns about vaccine safety and effectiveness. This highlights the need to enhance dissemination of information about COVID-19 vaccine. The lessons learnt in this study would be relevant for other emerging infections by informing vaccination implementation programs in similar settings. | |
dc.identifier.issn | 1549-1676 | |
dc.identifier.issn | PMID: 39495801 | |
dc.identifier.issn | PMCID: PMC11534251 | |
dc.identifier.uri | https://doi.org/10.1371/journal.pone.0312377 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12280/3217 | |
dc.language.iso | en | |
dc.publisher | PubMed Central - Public Library of Science | |
dc.relation.ispartofseries | Plos One | |
dc.subject | COVID-19 | |
dc.subject | COVID-19 vaccine | |
dc.subject | SARS-CoV-2 virus | |
dc.subject | World Health Organization | |
dc.subject | Pandemic | |
dc.subject | Uganda | |
dc.title | COVID-19 vaccine uptake and associated factors among individuals living in a peri-urban area in Uganda: a cross-sectional study | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Atuhaurwe-Article-Health-2024-COVID-19 vaccine uptake.pdf
- Size:
- 456.33 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: